Kindly find the attached Scrutinizer Report of the Extra Ordinary General Meeting held on 04-04-2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Limited (BSE SME, Code: 543594) submitted the Scrutinizer's Report for its Extra-Ordinary General Meeting (EGM) held on 4th April 2025 via Video Conferencing. The meeting, with cut-off date of 28th March 2025, had 3 resolutions put to vote through remote e-voting (1st–3rd April 2025). All three resolutions were passed with overwhelming shareholder support: 64,31,000 votes in favor (99.91%) and only 6,000 votes against (0.09%) on each resolution, with zero invalid votes. The voting was conducted via NSDL's electronic voting platform, scrutinized by Gaurav Bachani & Associates, Company Secretaries. The report has been countersigned by the Chairman and Managing Director Keyur Shah.
All three resolutions at the EGM passed with near-unanimous shareholder approval (99.91% in favor), indicating strong shareholder consensus and no governance concerns. This is a routine procedural filing confirming the EGM outcomes — no immediate impact on share price is expected, though the specific nature of the resolutions (not detailed in this document) may be material depending on what was approved.